We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTM
2226
ZoomInfo Technologies
GTM
$1.23B
| $186K | ﹤0.01% |
10,056
-103,494
| -91% | -$1.62M |
|
|
CFB
2227
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $185K | ﹤0.01% |
13,632
+766
| +6% | +$8.77K |
|
2228
CoreCivic
CXW
$3.26B
| $184K | ﹤0.01% |
+12,691
| New | +$168K |
|
|
VTNR
2229
DELISTED
Vertex Energy, Inc
VTNR
| $184K | ﹤0.01% |
54,181
-103,365
| -66% | -$406K |
|
|
LAND
2230
Gladstone Land Corp
LAND
$351M
| $183K | ﹤0.01% |
+12,674
| New | +$181K |
|
2231
Ardagh Metal Packaging
AMBP
$2.97B
| $183K | ﹤0.01% |
47,688
+8,699
| +22% | +$30.3K |
|
|
OSG
2232
DELISTED
Overseas Shipholding Group Inc.
OSG
| $175K | ﹤0.01% |
33,298
+5,068
| +18% | +$24.5K |
|
2233
Xponential Fitness
XPOF
$208M
| $175K | ﹤0.01% |
13,586
+3,275
| +32% | +$44.4K |
|
2234
Anavex Life Sciences
AVXL
$314M
| $173K | ﹤0.01% |
18,601
+1,809
| +11% | +$12.5K |
|
2235
American Coastal Insurance
ACIC
$470M
| $173K | ﹤0.01% |
18,282
+7,486
| +69% | +$60.2K |
|
2236
Janus International
JBI
$732M
| $170K | ﹤0.01% |
13,057
+2,833
| +28% | +$30.1K |
|
2237
Phathom Pharmaceuticals
PHAT
$693M
| $168K | ﹤0.01% |
18,427
-4,408
| -19% | -$38K |
|
2238
Verrica Pharmaceuticals
VRCA
$88M
| $164K | ﹤0.01% |
2,236
+39
| +2% | +$1.6K |
|
|
SILK
2239
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $162K | ﹤0.01% |
13,193
-2,209
| -14% | -$20.7K |
|
2240
HighPeak Energy
HPK
$1B
| $162K | ﹤0.01% |
11,358
-4,757
| -30% | -$75.4K |
|
2241
Lifestance Health
LFST
$4.55B
| $162K | ﹤0.01% |
20,653
-12,991
| -39% | -$83.7K |
|
2242
OptimizeRx
OPRX
$129M
| $160K | ﹤0.01% |
11,172
-1,183
| -10% | -$11.4K |
|
|
FPI
2243
Farmland Partners
FPI
$424M
| $158K | ﹤0.01% |
12,634
-525
| -4% | -$6.08K |
|
2244
Travere Therapeutics
TVTX
$5.74B
| $154K | ﹤0.01% |
17,183
-31,068
| -64% | -$226K |
|
2245
FIGS
FIGS
$2.39B
| $153K | ﹤0.01% |
22,033
-17,896
| -45% | -$118K |
|
2246
Bit Digital
BTBT
$454M
| $152K | ﹤0.01% |
+35,918
| New | +$93.8K |
|
2247
Olema Pharmaceuticals
OLMA
$1.04B
| $151K | ﹤0.01% |
10,781
+728
| +7% | +$9.78K |
|
2248
Replimune Group
REPL
$1.15B
| $150K | ﹤0.01% |
+17,825
| New | +$207K |
|
2249
Compass
COMP
$9.52B
| $150K | ﹤0.01% |
39,941
+12,959
| +48% | +$32K |
|
2250
Design Therapeutics
DSGN
$897M
| $149K | ﹤0.01% |
+56,240
| New | +$129K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.